SE411117B - Sett att framstella kernsubstituerade kanelsyraaminobensoesyraderivat - Google Patents

Sett att framstella kernsubstituerade kanelsyraaminobensoesyraderivat

Info

Publication number
SE411117B
SE411117B SE7400615A SE7400615A SE411117B SE 411117 B SE411117 B SE 411117B SE 7400615 A SE7400615 A SE 7400615A SE 7400615 A SE7400615 A SE 7400615A SE 411117 B SE411117 B SE 411117B
Authority
SE
Sweden
Prior art keywords
substituted cinnamic
nuclear substituted
acid derivatives
preparing nuclear
cinnamic acid
Prior art date
Application number
SE7400615A
Other languages
English (en)
Swedish (sv)
Inventor
K Harita
Y Ajisawa
K Iizuka
Y Kinoshita
T Kamijo
M Kobayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of SE411117B publication Critical patent/SE411117B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7400615A 1973-01-18 1974-01-17 Sett att framstella kernsubstituerade kanelsyraaminobensoesyraderivat SE411117B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP735973A JPS5640710B2 (xx) 1973-01-18 1973-01-18

Publications (1)

Publication Number Publication Date
SE411117B true SE411117B (sv) 1979-12-03

Family

ID=11663750

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7400615A SE411117B (sv) 1973-01-18 1974-01-17 Sett att framstella kernsubstituerade kanelsyraaminobensoesyraderivat

Country Status (18)

Country Link
US (2) US3940422A (xx)
JP (1) JPS5640710B2 (xx)
AT (1) AT333726B (xx)
BE (1) BE809935A (xx)
BG (1) BG24538A3 (xx)
CH (2) CH615152A5 (xx)
DE (1) DE2402398C3 (xx)
DK (1) DK139676C (xx)
ES (1) ES422395A1 (xx)
FI (1) FI60555C (xx)
FR (1) FR2214476B1 (xx)
GB (1) GB1446141A (xx)
HU (1) HU168055B (xx)
IT (1) IT1054151B (xx)
NL (1) NL179370C (xx)
NO (1) NO142441C (xx)
SE (1) SE411117B (xx)
SU (1) SU520041A3 (xx)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144250A (en) * 1973-05-14 1979-03-13 Stauffer Chemical Company Herbicidal active carboxanilide derivatives
JPS5830302B2 (ja) * 1974-04-16 1983-06-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
GB1484413A (en) * 1974-04-18 1977-09-01 Kissei Pharmaceutical Aromatic amidocarboxylic acid derivatives
DE2629752A1 (de) * 1976-07-02 1978-01-05 Boehringer Mannheim Gmbh Neue carbonsaeurederivate und verfahren zu ihrer herstellung
JPS56135454A (en) * 1980-03-26 1981-10-22 Kissei Pharmaceut Co Ltd Preparation of aromatic carboxylic acid amide derivative
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JPS5838244A (ja) * 1981-09-01 1983-03-05 Kissei Pharmaceut Co Ltd 核置換シンナモイルアントラニル酸塩およびその製造方法
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds
JPS6097946A (ja) * 1983-11-01 1985-05-31 Ono Pharmaceut Co Ltd カルボキサミド誘導体
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
JPS60142936A (ja) * 1983-12-28 1985-07-29 Ono Pharmaceut Co Ltd 置換フエニル誘導体
JPS60146857A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
JPS60146856A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
IT1196348B (it) * 1984-11-29 1988-11-16 Italfarmaco Spa Composti ad attivita'antiinfiammatoria
JPH078851B2 (ja) * 1985-07-29 1995-02-01 鐘淵化学工業株式会社 ３−フエニルチオメチルスチレン誘導体
JPH0733357B2 (ja) * 1986-09-30 1995-04-12 日本レダリ−株式会社 ケイ皮酸誘導体
JPH0692353B2 (ja) * 1987-05-26 1994-11-16 マルコ製薬株式会社 新規なアミノ安息香酸アミド誘導体およびその製造法
JP2632732B2 (ja) * 1989-11-06 1997-07-23 株式会社興人 Ｎ―（３’，４’―ジメトキシシンナモイル）アントラニル酸の製造方法
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
ATE406909T1 (de) * 1993-05-13 2008-09-15 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
KR19990082330A (ko) * 1996-02-06 1999-11-25 미즈노 마사루 신규 화합물 및 이의 의약 용도
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention
DE19935219A1 (de) * 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
DE10065042A1 (de) * 2000-12-23 2002-06-27 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
DE10065043A1 (de) * 2000-12-23 2002-07-04 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1318141A1 (en) * 2001-12-04 2003-06-11 Dsm Nv Process for treating an aqueous medium containing phosphate, cyclohexanone and cyclohexanone oxime
BR0117189B1 (pt) * 2001-12-04 2011-08-09 processo para tratar um meio aquoso que contém oxima de ciclohexanona e ciclohexanona.
PL373484A1 (en) * 2001-12-10 2005-09-05 Amgen Inc. Vanilloid receptor ligands and their use in treatments
NZ538663A (en) * 2002-08-29 2006-02-24 Univ Temple Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
DE10254872A1 (de) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
WO2005110392A1 (en) * 2004-05-14 2005-11-24 The University Of Melbourne Methods of modulating flt3 activity
WO2006076580A2 (en) 2005-01-14 2006-07-20 The Board Of Trustees Of The Leland Stanford Junior University A method of modulating t cell functioning
ITMI20050261A1 (it) * 2005-02-21 2006-08-22 Carlo Ghisalberti Analoghi strutturali di avenatramidi loro uso in composizioni utili nel trattamento di disordini dermatologici
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
EP1886662B1 (de) * 2006-06-14 2014-04-09 Symrise AG Antimikrobiell wirksame Verbindungen zur Behandlung von Mundgeruch
PT2035369E (pt) 2006-07-05 2014-09-30 Fibrotech Therapeutics Pty Ltd Compostos terapêuticos
WO2008131481A1 (en) * 2007-04-26 2008-11-06 Fibrotech Therapeutics Pty Ltd Treatment of mesangioproliferative diseases
CA2709937C (en) * 2007-12-21 2016-03-22 Fibrotech Therapeutics Pty Ltd Halogenated analogues of anti-fibrotic agents
WO2010071866A2 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Combination therapy for arthritis with tranilast
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010147184A1 (ja) 2009-06-17 2010-12-23 国立大学法人熊本大学 月経困難症の予防及び／又は治療薬
IN2012DN03312A (xx) 2009-10-22 2015-10-23 Fibrotech Therapeutics Pty Ltd
DE102009046115A1 (de) * 2009-10-28 2011-09-08 Bayer Schering Pharma Aktiengesellschaft Substituierte 3-Phenylpropansäuren und ihre Verwendung
JP5674823B2 (ja) * 2011-01-25 2015-02-25 三井化学アグロ株式会社 芳香族アミドカルボン酸誘導体の製造方法
WO2014186737A1 (en) * 2013-05-16 2014-11-20 The Johns Hopkins University Compositions and methods for chemical exchange saturation transfer (cest) based magnetic resonance imaging (mri)
CN104693063A (zh) * 2015-03-18 2015-06-10 中国药科大学制药有限公司 一种曲尼司特的合成方法
US11014873B2 (en) 2017-02-03 2021-05-25 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
CN110357789B (zh) * 2018-04-11 2022-09-30 华东理工大学 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043868A (en) * 1959-12-09 1962-07-10 Searle & Co N-xenylalkanoylaminoalkanoic acids and esters thereof
GB1074480A (en) * 1964-07-29 1967-07-05 Pfizer & Co C Amino acid derivatives and method of preparation
AT313463B (de) * 1968-05-18 1974-02-25 Rhodiaceta Ag Verfahren und Vorrichtung zur Herstellung eines Wirrfadens

Also Published As

Publication number Publication date
AU6461374A (en) 1975-07-17
USRE32944E (en) 1989-06-06
DK139676B (da) 1979-03-26
NO740137L (no) 1974-07-19
NL179370C (nl) 1986-09-01
FR2214476A1 (xx) 1974-08-19
AT333726B (de) 1976-12-10
NO142441C (no) 1980-08-20
NL179370B (nl) 1986-04-01
FI60555B (fi) 1981-10-30
NL7400754A (xx) 1974-07-22
GB1446141A (en) 1976-08-18
HU168055B (xx) 1976-02-28
CH615152A5 (en) 1980-01-15
ATA44374A (de) 1976-04-15
DE2402398B2 (de) 1980-10-09
BE809935A (fr) 1974-05-16
JPS4993335A (xx) 1974-09-05
CH613442A5 (xx) 1979-09-28
ES422395A1 (es) 1976-08-01
NO142441B (no) 1980-05-12
SU520041A3 (ru) 1976-06-30
FI60555C (fi) 1982-02-10
DE2402398A1 (de) 1974-08-08
JPS5640710B2 (xx) 1981-09-22
BG24538A3 (en) 1978-03-10
US3940422A (en) 1976-02-24
DE2402398C3 (de) 1981-07-23
FR2214476B1 (xx) 1977-08-12
IT1054151B (it) 1981-11-10
DK139676C (da) 1979-09-10

Similar Documents

Publication Publication Date Title
SE411117B (sv) Sett att framstella kernsubstituerade kanelsyraaminobensoesyraderivat
SE408712B (sv) Sett att framstelladubbelsalter av s-adenosyl-l-metionin
SE398876B (sv) Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE407577B (sv) Sett att framstella metallsalter av dialkyltiofosforsyra
SE391243B (sv) Sond for detektering av stralning
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE7510812L (sv) Sett att framstella ett nukleasresistent hydrofilt komplex av polyriboinosin-polyribocytidyl-syra
SE410607B (sv) Sett att framstella pregnan-21-syraderivat
SE411752B (sv) Forfarande for framstellning av substituerade aminobensoesyraderivat
SE407939B (sv) Sett att framstella 7-fluorsubstituerade fentiaziner med forlengd neurolopetisk effekt
SE422212B (sv) Forfarande for framstellning av 7beta-amino-3-metyl-cefam-4-karbonsyraforeningar
NO146198C (no) Mellomprodukt for fremstilling av 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-ind-2-en-3-yl-eddiksyre
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE416725B (sv) Forfarande for framstellning av p-nitrobensoesyra
SE403373B (sv) Sett att framstella aminosubstituerade tetracykliska foreningar
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SE411447B (sv) Sett att framstella 4-cyklopropylmetylenoxi- 3-klorfenylettiksyra
SE387944B (sv) Sett att framstella xanton-2-karbonsyraforeningar
SE409458B (sv) Sett att framstella 7-amino-desacetoxi-cefalosporansyra
SE403107B (sv) Sett att framstella 6-substituerade 3-etoxi-karbonyl hydrazino-pyridaziner
SE382063B (sv) Sett att framstella fenyl-vinylfosfonsyraderivat
SE387111B (sv) Sett att framstella bensoylfenylguanidiner
SE411452B (sv) Sett att framstella tienopyridinkarboxylsyraderivat
SE411342B (sv) Sett att framstella 4-acetamido-fenyl-3-acetoxibensoat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7400615-6

Effective date: 19940210

Format of ref document f/p: F